Metraipolis › archive › dc_835c8676c643
Differences in residual lesion detection after treatment of metastatic prostate cancer based on dual-tracer PET/CT — Europe PMC PMID:41907591
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41907591
- DOI
- 10.3389/fonc.2026.1713930
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T11:26:20.380Z
- SHA-256 of the archived text
ff309c878d2759274e5969bdf65f0c5da46647e19132a287fa7d4e7ca4547c47- Stable URL of this page
https://metraipolis.com/documento/dc_835c8676c643
How to cite
Differences in residual lesion detection after treatment of metastatic prostate cancer based on dual-tracer PET/CT — Europe PMC PMID:41907591 — Europe PMC (en), https://europepmc.org/article/MED/41907591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_835c8676c643 (Metraipolis archive dc_835c8676c643, sha256 ff309c878d2759274e5969bdf65f0c5da46647e19132a287fa7d4e7ca4547c47)
BibTeX
@misc{dc835c8676c643,
title = {Differences in residual lesion detection after treatment of metastatic prostate cancer based on dual-tracer PET/CT — Europe PMC PMID:41907591},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41907591},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_835c8676c643; sha256 ff309c878d2759274e5969bdf65f0c5da46647e19132a287fa7d4e7ca4547c47},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41907591. Agents can read the archived copy with the MCP tool read_document.